5-hydroxymethylcytosine has been researched along with phosphoserine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, DX; Fu, HL; Hou, P; Jin, WL; Li, BJ; Lu, LG; Ma, Y | 1 |
Adler, GK; Argueta, C; Chen, H; Chen, J; Dong, Z; Duquette, D; Fan, J; Fang, R; Fetahu, IS; Garg, R; Geng, S; Hu, D; Lan, F; Li, Y; Lian, CG; Liu, H; Lv, R; Lynch, L; Mao, F; Murphy, GF; Rabidou, K; Shi, G; Shi, Y; Shi, YG; Tan, L; Wang, M; Wu, D; Wu, F; Xu, S; Xu, Y; Yan, G; Yang, P; Ye, Y; Yin, C; Zhang, L; Zhang, S | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and phosphoserine
Article | Year |
---|---|
TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cytosine; Dioxygenases; DNA-Activated Protein Kinase; DNA-Binding Proteins; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gastric Mucosa; Humans; Ki-67 Antigen; Mice; Mixed Function Oxygenases; Nuclear Proteins; Phosphorylation; Phosphoserine; Polycomb Repressive Complex 2; Protein Binding; Proto-Oncogene Proteins; Signal Transduction; Stomach Neoplasms; Tissue Array Analysis; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer.
Topics: 5-Methylcytosine; Adenylate Kinase; Animals; Diabetes Mellitus; Dioxygenases; DNA; DNA Methylation; DNA-Binding Proteins; Enzyme Stability; Epigenesis, Genetic; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Metformin; Mice; Mice, Nude; Neoplasms; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins; Substrate Specificity; Xenograft Model Antitumor Assays | 2018 |